CONTACT:

Geri Berdak, Director of Public Affairs
The Solae Company
314/982-2588
and/or
Chris Short or Whitney Smith
Cushman/Amberg Communications, Inc.
312/263-2500

THE SOLAE COMPANY TEMPORARILY WITHDRAWS FDA HEALTH CLAIM PETITION
Soy Protein Manufacturer Cites Change in Evaluation Process as Catalyst for Decision

St. Louis, MO (September 30, 2005) – The Solae Company today announced it is temporarily withdrawing its request for a qualified health claim related to soy protein consumption and cancer prevention. The Solae Company made its decision after an analysis of recent FDA health claim decisions.

The company believes the relationship between consumption of soy protein and the prevention of cancer is strong but withdrew the claim because it felt the FDA’s process is new and its evaluation process is evolving. By making sure the petition meets the current criteria required for the restructured evaluation process, The Solae Company will be putting forward the strongest possible case based on the science for the FDA. The company’s objective in filing this petition was to enable research-based health information to be made more readily available to consumers.

“Our decision has nothing to do with our confidence in the science,” said Dr. Greg Paul, director of health and nutrition for The Solae Company. “We have an improved understanding of the process and have decided to withdraw the petition and re-structure it so it will be in-line with the FDA’s current qualified health claim process.”

Nearly 60 different independent research studies support the relationship between the consumption of soy protein-based foods and reduced risk of developing several types of cancer, and new studies continue to investigate such a link. For example, a study in this week’s Journal of the American Medical Association found that higher consumption of some soy products is associated with a reduced risk of lung cancer.

As leaders in the industry, The Solae Company will continue to spearhead research exploring the health benefits of soy protein and will continue to seek ways to communicate those benefits to consumers. The company plans to re-submit the petition to the FDA at a later date but no specific timelines have been set.

Headquartered in St. Louis, Missouri, The Solae Company is a global innovator in technology development and the research and application of soy protein. It serves food and beverage manufacturers, dietary supplement developers, retailers and consumers in 100 countries worldwide including the U.S. and Canada, Europe and the Middle East, Latin America and the Asia/Pacific region. The company was formed through an alliance between Bunge Limited (NYSE: BG) and DuPont (NYSE: DD). For more than 30 years, The Solae Company has invested in fundamental research to understand the health benefits of soy protein in order to provide better ingredients for better living. Researchers at more than 180 leading universities and research institutions have used soy protein products produced by The Solae Company in hundreds of completed and ongoing soy studies. For more about the health benefits of soy protein, including additional research and sources, please visit www.thesolaecompany.com.

# # #